Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH

National Medical Journal of China

Volumn 87, Issue 23, 2007, Pages 1590-1593

  Xiao, He ^a   Li, Han Zhong ^b   Yang, Yong ^b   Huang, Zhong Ming ^b   Li, Yong Qiang ^b   Zhao, Xiao Feng ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NONE

Author keywords

Adrenergic alpha antagonists; Drug therapy; Prostatic hyperlasia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; PROSTATE SPECIFIC ANTIGEN; TERAZOSIN; TOLTERODINE;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FLOW MEASUREMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; SYMPTOM; TREATMENT DURATION; URODYNAMICS;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; CHOLINERGIC ANTAGONISTS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 34548096395     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Peters, TJ, Donovan JL, Kay HE, et al. The international continence society "benign prostatic hyperplasia" study: the bothersomeness of urinary symptoms. J Urol, 1997, 157:885.
2. Roiser PF, de la Rosette JJ, Wijkstra H, et al. Is detrusor instability in elderly males related to the grade of obstruction? Neurourol Urodyn. 1995, 14:625.
3. Crawford ED. Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile. BJU International, 2005, 95(suppl 4):1-5.
4. Park CH, Chang HS, Oh BR, et al. Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Clin Drug Invest, 2004, 24:41-47.
5. Lee KS, Choo MS, Kim DY, et al. Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study. J Urol, 2005, 174:1334-1338.
6. Athanasopoulos A, Gyftopoulos K, Giannitsas K, et al. Combination treatment with an -blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study. Int Journal Urology, 2003, 169:2253-2256.
7. Lee JY, Kim HW, Lee SJ, et al. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU International, 2004, 94:817-820.